Early detection of cancer in the general population: a blinded case-control study of p53 autoantibodies in colorectal cancer. (Q36557829)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

title

Early detection of cancer in the general population: a blinded case-control study of p53 autoantibodies in colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

1 reference

early detection of cancer

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Usha Menon

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Hans H Wandall

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

J W Pedersen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

E-O Fourkala

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

A Dawnay

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

M Burnell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

A Zaikin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

A E Pedersen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

A Gentry-Maharaj

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

language of work or name

English

0 references

publication date

20 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

107-114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera

18 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Screening for colorectal cancer: possible improvements by risk assessment evaluation?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Comparison of candidate serologic markers for type I and type II ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Reproductive history and risk of colorectal cancer in postmenopausal women

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

The sine qua non of discovering novel biomarkers for early detection of ovarian cancer: carefully selected preclinical samples

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Confounding effects of hormone replacement therapy in protein biomarker studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Clinical validation of an autoantibody test for lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Sensitive digital quantification of DNA methylation in clinical samples

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Profiling tumor-associated antibodies for early detection of non-small cell lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Autoantibody signatures in prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

p53 autoantibodies predict subsequent development of cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

p53 autoantibodies from patients with colorectal cancer recognize common epitopes in the N- or C-terminus of p53.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

p53 Antibodies in the sera of patients with various types of cancer: a review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Anti-p53 Antibodies in Sera of Workers Occupationally Exposed to Vinyl Chloride

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Humoral response to p53 in human colorectal tumors: a prospective study of 1,209 patients.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Analysis of the anti-p53 antibody response in cancer patients.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Antibodies against p53 are associated with poor prognosis of colorectal cancer

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Seromic profiling of colorectal cancer patients with novel glycopeptide microarray

21 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2012.517

Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3553520

Comparison of the diagnostic accuracy of three commercially available enzyme immunoassays for anti-p53 antibodies

4 December 2018

1 reference

12 December 2020

Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer

1 reference

12 December 2020

Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy

1 reference

12 December 2020

Serum p53 antibodies as early markers of lung cancer

1 reference

12 December 2020

DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies

1 reference

12 December 2020

Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposes

1 reference

12 December 2020

Anti-p53 autoantibodies in colon cancer patients

1 reference

12 December 2020

p53 genetic alterations, protein expression and autoantibodies in human colorectal carcinoma: A comparative study

1 reference

12 December 2020

Anti-p53 autoantibody in colorectal cancer: prognostic significance in long-term follow-up

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2012.517

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

PubMed publication ID

23169294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23169294%20AND%20SRC:MED&resulttype=core&format=json